| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epithelial-Mesenchymal Transition | 26 | 2025 | 105 | 4.620 |
Why?
|
| Endocardium | 20 | 2023 | 78 | 4.040 |
Why?
|
| Heart | 18 | 2023 | 522 | 3.710 |
Why?
|
| Myocardium | 21 | 2023 | 570 | 3.610 |
Why?
|
| Transcription Factors | 34 | 2023 | 1691 | 3.400 |
Why?
|
| Receptor, Notch1 | 9 | 2021 | 101 | 3.120 |
Why?
|
| Signal Transduction | 48 | 2023 | 3502 | 2.630 |
Why?
|
| Gene Expression Regulation, Developmental | 26 | 2020 | 665 | 2.550 |
Why?
|
| Heart Valves | 10 | 2023 | 23 | 2.540 |
Why?
|
| beta Catenin | 10 | 2023 | 265 | 2.280 |
Why?
|
| Endocardial Cushions | 8 | 2023 | 8 | 2.250 |
Why?
|
| Breast Neoplasms | 24 | 2025 | 3110 | 2.130 |
Why?
|
| Animals | 141 | 2025 | 28155 | 2.030 |
Why?
|
| Neoplasm Metastasis | 21 | 2025 | 1061 | 2.020 |
Why?
|
| Snail Family Transcription Factors | 19 | 2025 | 48 | 2.010 |
Why?
|
| Mice | 97 | 2025 | 12269 | 1.920 |
Why?
|
| Neoplastic Stem Cells | 11 | 2024 | 172 | 1.890 |
Why?
|
| Nuclear Proteins | 16 | 2018 | 740 | 1.830 |
Why?
|
| NFATC Transcription Factors | 19 | 2023 | 50 | 1.740 |
Why?
|
| Neovascularization, Physiologic | 7 | 2021 | 140 | 1.740 |
Why?
|
| Aortic Valve | 8 | 2023 | 250 | 1.640 |
Why?
|
| Aortic Valve Stenosis | 4 | 2023 | 147 | 1.570 |
Why?
|
| Heart Valve Diseases | 4 | 2023 | 100 | 1.490 |
Why?
|
| Cell Transformation, Neoplastic | 13 | 2022 | 457 | 1.480 |
Why?
|
| Gene Expression Regulation, Neoplastic | 16 | 2025 | 1338 | 1.390 |
Why?
|
| Coronary Vessels | 5 | 2021 | 178 | 1.370 |
Why?
|
| Endothelial Cells | 14 | 2023 | 477 | 1.340 |
Why?
|
| Neovascularization, Pathologic | 6 | 2021 | 353 | 1.330 |
Why?
|
| Organogenesis | 9 | 2022 | 50 | 1.280 |
Why?
|
| Cadherins | 8 | 2016 | 180 | 1.190 |
Why?
|
| Morphogenesis | 13 | 2021 | 206 | 1.120 |
Why?
|
| Heart Defects, Congenital | 9 | 2022 | 367 | 1.110 |
Why?
|
| Cell Line, Tumor | 36 | 2025 | 2755 | 1.100 |
Why?
|
| Mesoderm | 13 | 2019 | 122 | 1.080 |
Why?
|
| Twist-Related Protein 1 | 4 | 2018 | 16 | 1.070 |
Why?
|
| Bone Morphogenetic Protein 2 | 3 | 2018 | 62 | 1.050 |
Why?
|
| Cell Movement | 16 | 2025 | 809 | 1.040 |
Why?
|
| Cell Proliferation | 25 | 2024 | 1741 | 1.040 |
Why?
|
| Cellular Reprogramming | 3 | 2025 | 50 | 1.020 |
Why?
|
| Heart Ventricles | 6 | 2023 | 650 | 0.990 |
Why?
|
| NF-kappa B | 11 | 2024 | 408 | 0.960 |
Why?
|
| Epithelial Cells | 10 | 2024 | 700 | 0.950 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2021 | 304 | 0.940 |
Why?
|
| Myocytes, Cardiac | 9 | 2019 | 313 | 0.920 |
Why?
|
| Mice, Knockout | 24 | 2022 | 2121 | 0.900 |
Why?
|
| Repressor Proteins | 5 | 2024 | 443 | 0.890 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 5 | 2017 | 61 | 0.890 |
Why?
|
| Myosin Heavy Chains | 4 | 2022 | 86 | 0.880 |
Why?
|
| Neoplasm Invasiveness | 14 | 2017 | 572 | 0.860 |
Why?
|
| Receptors, G-Protein-Coupled | 10 | 2024 | 163 | 0.820 |
Why?
|
| Histone Demethylases | 2 | 2014 | 34 | 0.810 |
Why?
|
| Inflammation | 8 | 2023 | 1050 | 0.810 |
Why?
|
| Calcium-Binding Proteins | 4 | 2021 | 119 | 0.810 |
Why?
|
| Embryo, Mammalian | 12 | 2023 | 217 | 0.790 |
Why?
|
| Stem Cells | 10 | 2022 | 387 | 0.770 |
Why?
|
| Receptors, Notch | 3 | 2018 | 138 | 0.770 |
Why?
|
| DNA-Binding Proteins | 10 | 2019 | 1234 | 0.750 |
Why?
|
| Calcinosis | 4 | 2023 | 222 | 0.740 |
Why?
|
| Neoplasms | 11 | 2025 | 3169 | 0.730 |
Why?
|
| Cell Cycle Proteins | 7 | 2020 | 409 | 0.730 |
Why?
|
| Sinoatrial Node | 2 | 2020 | 12 | 0.710 |
Why?
|
| Promoter Regions, Genetic | 13 | 2025 | 962 | 0.700 |
Why?
|
| Wnt-5a Protein | 2 | 2018 | 10 | 0.680 |
Why?
|
| Proto-Oncogene Proteins c-akt | 9 | 2021 | 366 | 0.670 |
Why?
|
| Venous Valves | 1 | 2020 | 1 | 0.650 |
Why?
|
| Coronary Sinus | 1 | 2020 | 11 | 0.640 |
Why?
|
| Cell Lineage | 7 | 2019 | 321 | 0.640 |
Why?
|
| Wnt Proteins | 6 | 2019 | 127 | 0.620 |
Why?
|
| Humans | 94 | 2025 | 93515 | 0.610 |
Why?
|
| DNA Methylation | 5 | 2017 | 697 | 0.600 |
Why?
|
| Gene Expression Regulation | 12 | 2019 | 1985 | 0.600 |
Why?
|
| Muscle, Smooth, Vascular | 7 | 2022 | 232 | 0.590 |
Why?
|
| Mice, Transgenic | 17 | 2021 | 1587 | 0.590 |
Why?
|
| Cells, Cultured | 20 | 2021 | 2850 | 0.580 |
Why?
|
| Macrophages | 6 | 2019 | 610 | 0.580 |
Why?
|
| Carcinogenesis | 6 | 2022 | 235 | 0.570 |
Why?
|
| Histocompatibility Antigens | 3 | 2015 | 37 | 0.570 |
Why?
|
| Regeneration | 4 | 2016 | 159 | 0.570 |
Why?
|
| Cell Differentiation | 16 | 2023 | 1621 | 0.560 |
Why?
|
| Vascular Endothelial Growth Factor A | 5 | 2018 | 398 | 0.540 |
Why?
|
| Histone-Lysine N-Methyltransferase | 4 | 2015 | 166 | 0.540 |
Why?
|
| Fucosyltransferases | 1 | 2017 | 9 | 0.530 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2017 | 78 | 0.530 |
Why?
|
| Lung Neoplasms | 9 | 2024 | 2365 | 0.520 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 28 | 0.520 |
Why?
|
| Autophagy | 3 | 2015 | 172 | 0.520 |
Why?
|
| Membrane Proteins | 8 | 2021 | 1264 | 0.510 |
Why?
|
| Gene Deletion | 9 | 2021 | 352 | 0.510 |
Why?
|
| Microtubule-Associated Proteins | 6 | 2015 | 185 | 0.510 |
Why?
|
| Gene Silencing | 2 | 2017 | 177 | 0.510 |
Why?
|
| ErbB Receptors | 7 | 2022 | 506 | 0.500 |
Why?
|
| Glycogen Synthase Kinase 3 | 5 | 2012 | 69 | 0.500 |
Why?
|
| Phenotype | 11 | 2021 | 2544 | 0.490 |
Why?
|
| Endopeptidases | 1 | 2017 | 116 | 0.490 |
Why?
|
| Ubiquitin-Protein Ligases | 3 | 2019 | 183 | 0.490 |
Why?
|
| Tetraspanin 24 | 4 | 2019 | 5 | 0.490 |
Why?
|
| Proteolysis | 1 | 2017 | 123 | 0.480 |
Why?
|
| Apoptosis | 8 | 2023 | 1721 | 0.480 |
Why?
|
| Cell Nucleus | 5 | 2019 | 603 | 0.480 |
Why?
|
| GATA4 Transcription Factor | 1 | 2016 | 19 | 0.480 |
Why?
|
| T-Box Domain Proteins | 4 | 2020 | 127 | 0.480 |
Why?
|
| Swine | 4 | 2023 | 588 | 0.470 |
Why?
|
| HEK293 Cells | 10 | 2020 | 696 | 0.460 |
Why?
|
| PTEN Phosphohydrolase | 2 | 2014 | 147 | 0.460 |
Why?
|
| Fibroblast Growth Factors | 1 | 2016 | 86 | 0.460 |
Why?
|
| Poly(ADP-ribose) Polymerases | 3 | 2014 | 56 | 0.450 |
Why?
|
| Mice, Nude | 16 | 2025 | 824 | 0.440 |
Why?
|
| Female | 47 | 2025 | 48702 | 0.440 |
Why?
|
| Fibronectins | 5 | 2009 | 100 | 0.440 |
Why?
|
| Up-Regulation | 11 | 2025 | 730 | 0.440 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2014 | 5 | 0.420 |
Why?
|
| Blotting, Western | 10 | 2015 | 784 | 0.420 |
Why?
|
| Models, Biological | 6 | 2021 | 1768 | 0.410 |
Why?
|
| Mice, SCID | 6 | 2020 | 271 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 14 | 2021 | 3435 | 0.410 |
Why?
|
| Sex Factors | 1 | 2017 | 1105 | 0.410 |
Why?
|
| Wnt Signaling Pathway | 4 | 2020 | 103 | 0.410 |
Why?
|
| RNA Polymerase II | 1 | 2014 | 60 | 0.410 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2014 | 63 | 0.400 |
Why?
|
| Neoplasm Proteins | 3 | 2024 | 537 | 0.400 |
Why?
|
| Wnt4 Protein | 1 | 2013 | 4 | 0.390 |
Why?
|
| Drug Delivery Systems | 1 | 2015 | 194 | 0.390 |
Why?
|
| Fructose-Bisphosphatase | 1 | 2013 | 3 | 0.390 |
Why?
|
| STAT3 Transcription Factor | 3 | 2025 | 87 | 0.390 |
Why?
|
| Ubiquitin Thiolesterase | 1 | 2013 | 66 | 0.390 |
Why?
|
| Antineoplastic Agents | 5 | 2020 | 2303 | 0.390 |
Why?
|
| Doxorubicin | 1 | 2014 | 284 | 0.380 |
Why?
|
| F-Box Proteins | 1 | 2012 | 14 | 0.380 |
Why?
|
| Coronary Artery Disease | 1 | 2017 | 375 | 0.380 |
Why?
|
| Tumor Microenvironment | 7 | 2024 | 554 | 0.370 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 105 | 0.360 |
Why?
|
| Emodin | 1 | 2021 | 6 | 0.360 |
Why?
|
| Protein Binding | 9 | 2018 | 1534 | 0.360 |
Why?
|
| Proto-Oncogene Proteins | 5 | 2014 | 666 | 0.350 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 3 | 2018 | 179 | 0.340 |
Why?
|
| Histones | 5 | 2019 | 361 | 0.340 |
Why?
|
| Real-Time Polymerase Chain Reaction | 4 | 2017 | 296 | 0.340 |
Why?
|
| Lysine | 2 | 2010 | 182 | 0.340 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2023 | 688 | 0.340 |
Why?
|
| Troponin T | 2 | 2016 | 42 | 0.330 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 555 | 0.330 |
Why?
|
| Trans-Activators | 4 | 2010 | 439 | 0.330 |
Why?
|
| Neuregulin-1 | 3 | 2020 | 17 | 0.330 |
Why?
|
| Phosphorylation | 11 | 2017 | 1133 | 0.330 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2012 | 298 | 0.320 |
Why?
|
| Extracellular Matrix | 6 | 2020 | 256 | 0.320 |
Why?
|
| Monoamine Oxidase | 1 | 2010 | 24 | 0.320 |
Why?
|
| Gene Knockdown Techniques | 3 | 2017 | 254 | 0.320 |
Why?
|
| Protein Biosynthesis | 5 | 2009 | 376 | 0.320 |
Why?
|
| Receptor, ErbB-2 | 4 | 2005 | 280 | 0.310 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 6 | 2017 | 43 | 0.310 |
Why?
|
| Rats | 12 | 2021 | 4072 | 0.310 |
Why?
|
| Triple Negative Breast Neoplasms | 2 | 2024 | 190 | 0.310 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2016 | 308 | 0.310 |
Why?
|
| Cell Survival | 6 | 2020 | 1004 | 0.300 |
Why?
|
| Transcription, Genetic | 6 | 2015 | 1117 | 0.300 |
Why?
|
| Mitral Valve | 5 | 2023 | 225 | 0.300 |
Why?
|
| Mitral Valve Prolapse | 2 | 2023 | 18 | 0.290 |
Why?
|
| Mice, Inbred ICR | 3 | 2014 | 75 | 0.290 |
Why?
|
| Peptide Fragments | 3 | 2022 | 470 | 0.290 |
Why?
|
| Myeloid-Derived Suppressor Cells | 3 | 2024 | 29 | 0.290 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2008 | 58 | 0.290 |
Why?
|
| Neural Crest | 2 | 2022 | 34 | 0.290 |
Why?
|
| Transfection | 9 | 2016 | 880 | 0.280 |
Why?
|
| MicroRNAs | 5 | 2021 | 580 | 0.280 |
Why?
|
| Calcineurin | 4 | 2013 | 19 | 0.280 |
Why?
|
| Immunohistochemistry | 9 | 2019 | 1799 | 0.280 |
Why?
|
| Animals, Newborn | 6 | 2017 | 522 | 0.280 |
Why?
|
| HSP47 Heat-Shock Proteins | 2 | 2020 | 3 | 0.270 |
Why?
|
| Mammary Glands, Animal | 2 | 2021 | 81 | 0.270 |
Why?
|
| Ubiquitination | 2 | 2019 | 78 | 0.270 |
Why?
|
| Binding Sites | 6 | 2017 | 1133 | 0.270 |
Why?
|
| Down-Regulation | 5 | 2017 | 524 | 0.260 |
Why?
|
| Superoxides | 2 | 2019 | 75 | 0.260 |
Why?
|
| Interleukin-6 | 2 | 2019 | 276 | 0.250 |
Why?
|
| Heart Atria | 3 | 2018 | 248 | 0.250 |
Why?
|
| Disease Models, Animal | 8 | 2020 | 2495 | 0.250 |
Why?
|
| HeLa Cells | 4 | 2014 | 517 | 0.250 |
Why?
|
| Protein Kinases | 1 | 2007 | 210 | 0.250 |
Why?
|
| Peptides | 1 | 2010 | 656 | 0.250 |
Why?
|
| Microtubules | 2 | 2015 | 134 | 0.250 |
Why?
|
| Collagen | 5 | 2020 | 304 | 0.240 |
Why?
|
| Adenocarcinoma | 2 | 2016 | 1173 | 0.240 |
Why?
|
| Proto-Oncogene Proteins c-sis | 2 | 2023 | 29 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 9 | 2025 | 1101 | 0.230 |
Why?
|
| Aging | 2 | 2015 | 727 | 0.230 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 7 | 0.230 |
Why?
|
| Integrin alpha3beta1 | 2 | 2015 | 4 | 0.230 |
Why?
|
| Mutation | 10 | 2018 | 4272 | 0.230 |
Why?
|
| Enzyme Inhibitors | 4 | 2015 | 641 | 0.220 |
Why?
|
| Ossification, Heterotopic | 2 | 2015 | 32 | 0.220 |
Why?
|
| RNA, Messenger | 8 | 2020 | 2026 | 0.220 |
Why?
|
| Blood Pressure | 3 | 2019 | 896 | 0.220 |
Why?
|
| Cell Cycle | 2 | 2023 | 515 | 0.220 |
Why?
|
| Disease Progression | 6 | 2016 | 1531 | 0.210 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2005 | 295 | 0.210 |
Why?
|
| Nerve Tissue Proteins | 2 | 2021 | 502 | 0.210 |
Why?
|
| Organ Specificity | 5 | 2016 | 279 | 0.210 |
Why?
|
| Lung | 6 | 2024 | 1366 | 0.210 |
Why?
|
| Zebrafish Proteins | 2 | 2017 | 159 | 0.210 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2003 | 302 | 0.210 |
Why?
|
| Cardiomegaly | 3 | 2014 | 111 | 0.200 |
Why?
|
| Lipid Metabolism | 1 | 2025 | 214 | 0.200 |
Why?
|
| Base Sequence | 5 | 2021 | 2220 | 0.200 |
Why?
|
| Biological Assay | 1 | 2023 | 82 | 0.200 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 3 | 2023 | 1133 | 0.200 |
Why?
|
| Molecular Sequence Data | 6 | 2016 | 2910 | 0.200 |
Why?
|
| DNA Helicases | 3 | 2014 | 89 | 0.200 |
Why?
|
| Cell Line | 10 | 2018 | 2464 | 0.200 |
Why?
|
| Cytosol | 1 | 2023 | 193 | 0.190 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2019 | 282 | 0.190 |
Why?
|
| Transcriptional Activation | 6 | 2024 | 290 | 0.190 |
Why?
|
| Catheters | 1 | 2023 | 96 | 0.190 |
Why?
|
| Cell Hypoxia | 3 | 2013 | 187 | 0.190 |
Why?
|
| Tumor Escape | 2 | 2020 | 53 | 0.190 |
Why?
|
| Chondrocytes | 1 | 2023 | 66 | 0.190 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferase 1 | 2 | 2013 | 20 | 0.190 |
Why?
|
| Aorta | 2 | 2021 | 273 | 0.190 |
Why?
|
| Myocytes, Smooth Muscle | 2 | 2021 | 134 | 0.190 |
Why?
|
| HMGB Proteins | 1 | 2022 | 3 | 0.190 |
Why?
|
| SOXF Transcription Factors | 1 | 2022 | 10 | 0.190 |
Why?
|
| Integrins | 2 | 2020 | 79 | 0.190 |
Why?
|
| Cartilage, Articular | 1 | 2023 | 77 | 0.180 |
Why?
|
| Cyclins | 1 | 2002 | 80 | 0.180 |
Why?
|
| Chromatin | 3 | 2016 | 440 | 0.180 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2017 | 215 | 0.180 |
Why?
|
| Gene Expression | 5 | 2016 | 1301 | 0.180 |
Why?
|
| Endothelium, Vascular | 2 | 2021 | 436 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2014 | 139 | 0.180 |
Why?
|
| Male | 21 | 2021 | 44557 | 0.180 |
Why?
|
| Ultrasonic Waves | 1 | 2021 | 6 | 0.180 |
Why?
|
| In Situ Hybridization | 3 | 2018 | 309 | 0.180 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2015 | 887 | 0.180 |
Why?
|
| Pancreatic Neoplasms | 3 | 2016 | 715 | 0.180 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2013 | 192 | 0.170 |
Why?
|
| Sympathetic Nervous System | 2 | 2019 | 99 | 0.170 |
Why?
|
| Colonic Neoplasms | 3 | 2015 | 579 | 0.170 |
Why?
|
| Angiotensin II | 1 | 2021 | 94 | 0.170 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 3 | 2015 | 76 | 0.170 |
Why?
|
| Fibroblasts | 5 | 2016 | 756 | 0.170 |
Why?
|
| PPAR gamma | 1 | 2021 | 75 | 0.170 |
Why?
|
| Excitatory Amino Acid Transporter 3 | 1 | 2020 | 6 | 0.170 |
Why?
|
| Cystine | 1 | 2020 | 18 | 0.170 |
Why?
|
| Transforming Growth Factor beta | 3 | 2015 | 347 | 0.170 |
Why?
|
| Gene Expression Profiling | 6 | 2023 | 1518 | 0.160 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2017 | 66 | 0.160 |
Why?
|
| Wnt2 Protein | 1 | 2020 | 7 | 0.160 |
Why?
|
| Glutathione | 1 | 2020 | 105 | 0.160 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2017 | 109 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2017 | 26 | 0.160 |
Why?
|
| Osteogenesis | 2 | 2020 | 274 | 0.160 |
Why?
|
| Recombinant Fusion Proteins | 4 | 2016 | 555 | 0.160 |
Why?
|
| Prostaglandin-E Synthases | 1 | 2020 | 3 | 0.160 |
Why?
|
| Glutamic Acid | 1 | 2020 | 147 | 0.160 |
Why?
|
| Dinoprostone | 1 | 2020 | 71 | 0.160 |
Why?
|
| Carcinoma, Lewis Lung | 1 | 2019 | 24 | 0.160 |
Why?
|
| Alleles | 1 | 2023 | 1139 | 0.160 |
Why?
|
| Biomarkers, Tumor | 3 | 2018 | 1660 | 0.160 |
Why?
|
| Tumor Cells, Cultured | 5 | 2015 | 1028 | 0.150 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2017 | 392 | 0.150 |
Why?
|
| Heart Failure | 3 | 2022 | 1386 | 0.150 |
Why?
|
| Angiotensin I | 1 | 2019 | 7 | 0.150 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 2019 | 7 | 0.150 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 3 | 2014 | 29 | 0.150 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2020 | 72 | 0.150 |
Why?
|
| Matrix Metalloproteinase 9 | 3 | 2015 | 83 | 0.150 |
Why?
|
| Blood Platelets | 1 | 2020 | 150 | 0.150 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 255 | 0.150 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2015 | 691 | 0.150 |
Why?
|
| Forkhead Box Protein O3 | 1 | 2018 | 21 | 0.150 |
Why?
|
| Protein Transport | 2 | 2018 | 438 | 0.150 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2019 | 69 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2018 | 17 | 0.140 |
Why?
|
| RNA Interference | 4 | 2015 | 379 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 198 | 0.140 |
Why?
|
| Ductus Arteriosus | 1 | 1998 | 28 | 0.140 |
Why?
|
| Sildenafil Citrate | 1 | 2018 | 24 | 0.140 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 2 | 2013 | 47 | 0.140 |
Why?
|
| Epinephrine | 1 | 2019 | 92 | 0.140 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2018 | 13 | 0.140 |
Why?
|
| Echocardiography | 3 | 2017 | 745 | 0.140 |
Why?
|
| Paracrine Communication | 1 | 2018 | 32 | 0.140 |
Why?
|
| Biomarkers | 4 | 2019 | 1910 | 0.140 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 1 | 2018 | 4 | 0.140 |
Why?
|
| Neoplasm Transplantation | 3 | 2015 | 399 | 0.140 |
Why?
|
| Sulfonamides | 2 | 2020 | 331 | 0.140 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2015 | 216 | 0.140 |
Why?
|
| Oligopeptides | 1 | 2019 | 191 | 0.140 |
Why?
|
| Acetylation | 2 | 2018 | 149 | 0.140 |
Why?
|
| I-kappa B Kinase | 3 | 2020 | 41 | 0.140 |
Why?
|
| RNAi Therapeutics | 1 | 2017 | 2 | 0.140 |
Why?
|
| Isocitrate Dehydrogenase | 2 | 2015 | 61 | 0.140 |
Why?
|
| Models, Genetic | 3 | 2013 | 970 | 0.130 |
Why?
|
| Cytokines | 3 | 2015 | 863 | 0.130 |
Why?
|
| Lipopolysaccharides | 2 | 2016 | 301 | 0.130 |
Why?
|
| Mice, Inbred NOD | 2 | 2019 | 216 | 0.130 |
Why?
|
| Codon, Nonsense | 1 | 2017 | 47 | 0.130 |
Why?
|
| Prognosis | 7 | 2025 | 3911 | 0.130 |
Why?
|
| Flow Cytometry | 4 | 2015 | 712 | 0.130 |
Why?
|
| Cell Growth Processes | 2 | 2016 | 83 | 0.130 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2017 | 3 | 0.130 |
Why?
|
| MCF-7 Cells | 4 | 2019 | 120 | 0.130 |
Why?
|
| Pro-Opiomelanocortin | 1 | 2017 | 13 | 0.130 |
Why?
|
| RNA, Small Interfering | 3 | 2015 | 555 | 0.130 |
Why?
|
| Jagged-1 Protein | 2 | 2016 | 14 | 0.130 |
Why?
|
| Epithelium | 2 | 2015 | 316 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2018 | 603 | 0.130 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2017 | 83 | 0.130 |
Why?
|
| DNA Damage | 1 | 2019 | 389 | 0.130 |
Why?
|
| Protein Stability | 1 | 2017 | 103 | 0.120 |
Why?
|
| Computer Simulation | 1 | 2021 | 1118 | 0.120 |
Why?
|
| Carcinogens | 1 | 2017 | 101 | 0.120 |
Why?
|
| Databases, Factual | 1 | 2021 | 1006 | 0.120 |
Why?
|
| Electron Transport Complex I | 2 | 2015 | 34 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 2 | 2015 | 58 | 0.120 |
Why?
|
| Gene Regulatory Networks | 2 | 2019 | 317 | 0.120 |
Why?
|
| Methylation | 3 | 2015 | 288 | 0.120 |
Why?
|
| Phosphoproteins | 1 | 2017 | 259 | 0.120 |
Why?
|
| CpG Islands | 1 | 2017 | 168 | 0.120 |
Why?
|
| Epiregulin | 1 | 2016 | 3 | 0.120 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2008 | 110 | 0.120 |
Why?
|
| Twist Transcription Factors | 1 | 2016 | 2 | 0.120 |
Why?
|
| Perioperative Care | 1 | 2018 | 188 | 0.120 |
Why?
|
| Asymmetric Cell Division | 1 | 2016 | 3 | 0.120 |
Why?
|
| Pericardium | 2 | 2014 | 72 | 0.120 |
Why?
|
| Dependovirus | 1 | 2016 | 37 | 0.120 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2016 | 22 | 0.120 |
Why?
|
| Ovarian Neoplasms | 2 | 2014 | 797 | 0.120 |
Why?
|
| RNA-Binding Proteins | 2 | 1999 | 306 | 0.120 |
Why?
|
| Substrate Specificity | 2 | 2008 | 363 | 0.120 |
Why?
|
| Beclin-1 | 1 | 2015 | 15 | 0.120 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2016 | 43 | 0.120 |
Why?
|
| Cardiomyopathies | 2 | 2016 | 291 | 0.120 |
Why?
|
| Hexamethonium | 1 | 2015 | 4 | 0.120 |
Why?
|
| Stress, Psychological | 1 | 2019 | 342 | 0.120 |
Why?
|
| Hyaluronan Receptors | 2 | 2017 | 40 | 0.120 |
Why?
|
| Silicon Dioxide | 1 | 2015 | 39 | 0.120 |
Why?
|
| Glycolysis | 2 | 2015 | 187 | 0.120 |
Why?
|
| G2 Phase Cell Cycle Checkpoints | 1 | 2015 | 14 | 0.120 |
Why?
|
| Sp1 Transcription Factor | 1 | 2015 | 24 | 0.120 |
Why?
|
| Placenta | 1 | 2017 | 189 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2015 | 80 | 0.110 |
Why?
|
| Nanoparticles | 1 | 2017 | 198 | 0.110 |
Why?
|
| Environmental Exposure | 2 | 2015 | 355 | 0.110 |
Why?
|
| Protein Phosphatase 2 | 1 | 2015 | 17 | 0.110 |
Why?
|
| Hazardous Substances | 1 | 2015 | 7 | 0.110 |
Why?
|
| CDC2 Protein Kinase | 1 | 2015 | 46 | 0.110 |
Why?
|
| Collagen Type I | 2 | 2014 | 74 | 0.110 |
Why?
|
| Sheep | 4 | 1999 | 203 | 0.110 |
Why?
|
| Biomedical Research | 1 | 2020 | 438 | 0.110 |
Why?
|
| Metabolic Engineering | 1 | 2015 | 4 | 0.110 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2016 | 81 | 0.110 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2015 | 5 | 0.110 |
Why?
|
| Genetic Markers | 1 | 2016 | 469 | 0.110 |
Why?
|
| Immunoenzyme Techniques | 2 | 2014 | 293 | 0.110 |
Why?
|
| Segmental Duplications, Genomic | 1 | 2015 | 7 | 0.110 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2015 | 98 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 13 | 0.110 |
Why?
|
| Receptor, TIE-1 | 1 | 2015 | 3 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 101 | 0.110 |
Why?
|
| Bone Development | 1 | 2015 | 38 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 2015 | 40 | 0.110 |
Why?
|
| Cleft Palate | 1 | 2015 | 27 | 0.110 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 502 | 0.110 |
Why?
|
| Lysosomes | 1 | 2015 | 123 | 0.110 |
Why?
|
| Potassium Channels | 1 | 2017 | 346 | 0.110 |
Why?
|
| Endothelin-1 | 1 | 2015 | 41 | 0.110 |
Why?
|
| Membrane Glycoproteins | 1 | 2017 | 444 | 0.110 |
Why?
|
| Bone Neoplasms | 3 | 2012 | 313 | 0.110 |
Why?
|
| Lymphatic System | 1 | 2015 | 54 | 0.110 |
Why?
|
| Stromal Cells | 1 | 2015 | 151 | 0.110 |
Why?
|
| Hyaluronan Synthases | 1 | 2014 | 10 | 0.110 |
Why?
|
| Axons | 1 | 2015 | 179 | 0.110 |
Why?
|
| Genes, Developmental | 1 | 2014 | 6 | 0.110 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2019 | 79 | 0.110 |
Why?
|
| Cell Death | 3 | 2020 | 253 | 0.110 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 369 | 0.110 |
Why?
|
| Homeostasis | 1 | 2017 | 460 | 0.110 |
Why?
|
| Genotype | 2 | 2016 | 1866 | 0.110 |
Why?
|
| Wound Healing | 2 | 2015 | 373 | 0.110 |
Why?
|
| Tetrazolium Salts | 1 | 2014 | 11 | 0.110 |
Why?
|
| Lysine Acetyltransferase 5 | 1 | 2014 | 2 | 0.100 |
Why?
|
| Sequence Deletion | 1 | 2015 | 209 | 0.100 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2014 | 68 | 0.100 |
Why?
|
| Hemodynamics | 1 | 2017 | 713 | 0.100 |
Why?
|
| Pancreas | 1 | 2016 | 258 | 0.100 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2014 | 156 | 0.100 |
Why?
|
| Lymphatic Vessels | 1 | 2015 | 69 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 1 | 2015 | 200 | 0.100 |
Why?
|
| Histone Acetyltransferases | 1 | 2014 | 45 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2014 | 251 | 0.100 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2024 | 47 | 0.100 |
Why?
|
| Stem Cell Niche | 1 | 2014 | 23 | 0.100 |
Why?
|
| Phthalazines | 1 | 2014 | 53 | 0.100 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2014 | 82 | 0.100 |
Why?
|
| Genes, Reporter | 3 | 2016 | 275 | 0.100 |
Why?
|
| Thiazoles | 1 | 2014 | 124 | 0.100 |
Why?
|
| Transcription Elongation, Genetic | 1 | 2013 | 5 | 0.100 |
Why?
|
| Glucose | 2 | 2015 | 692 | 0.100 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2013 | 13 | 0.100 |
Why?
|
| Hypoxia | 2 | 2017 | 675 | 0.100 |
Why?
|
| Antihypertensive Agents | 1 | 2015 | 261 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2015 | 663 | 0.100 |
Why?
|
| Hair Follicle | 1 | 2013 | 28 | 0.100 |
Why?
|
| TCF Transcription Factors | 1 | 2013 | 24 | 0.100 |
Why?
|
| Glucuronosyltransferase | 1 | 2014 | 184 | 0.100 |
Why?
|
| Glioblastoma | 1 | 2015 | 281 | 0.100 |
Why?
|
| RNA, Long Noncoding | 1 | 2014 | 129 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 2 | 2003 | 33 | 0.100 |
Why?
|
| Osteosarcoma | 2 | 2012 | 158 | 0.090 |
Why?
|
| Triterpenes | 1 | 2012 | 8 | 0.090 |
Why?
|
| Heart Septum | 1 | 2012 | 45 | 0.090 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2013 | 132 | 0.090 |
Why?
|
| Myxoma | 1 | 2012 | 28 | 0.090 |
Why?
|
| Cytoplasm | 2 | 2004 | 278 | 0.090 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2012 | 36 | 0.090 |
Why?
|
| Saponins | 1 | 2012 | 41 | 0.090 |
Why?
|
| Piperazines | 1 | 2014 | 284 | 0.090 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2012 | 1 | 0.090 |
Why?
|
| Keratinocytes | 1 | 2013 | 146 | 0.090 |
Why?
|
| Contractile Proteins | 1 | 2012 | 52 | 0.090 |
Why?
|
| Transplantation, Heterologous | 4 | 2016 | 371 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2012 | 13 | 0.090 |
Why?
|
| Oxygen Consumption | 1 | 2013 | 238 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2015 | 383 | 0.090 |
Why?
|
| Cytoskeletal Proteins | 2 | 2003 | 223 | 0.090 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2021 | 29 | 0.090 |
Why?
|
| Pregnancy | 7 | 2018 | 3147 | 0.090 |
Why?
|
| Pulmonary Valve | 1 | 2012 | 34 | 0.090 |
Why?
|
| Sepsis | 1 | 2016 | 388 | 0.090 |
Why?
|
| Cardiotonic Agents | 1 | 2012 | 88 | 0.090 |
Why?
|
| Middle Aged | 6 | 2025 | 27573 | 0.090 |
Why?
|
| Receptors, Cell Surface | 2 | 2017 | 292 | 0.090 |
Why?
|
| Tissue Culture Techniques | 1 | 2012 | 81 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 123 | 0.090 |
Why?
|
| Cation Transport Proteins | 1 | 2011 | 61 | 0.090 |
Why?
|
| Wnt3 Protein | 1 | 2011 | 13 | 0.080 |
Why?
|
| Retinal Dehydrogenase | 1 | 2011 | 7 | 0.080 |
Why?
|
| Reperfusion Injury | 1 | 2012 | 148 | 0.080 |
Why?
|
| Microfilament Proteins | 1 | 2012 | 209 | 0.080 |
Why?
|
| Smad4 Protein | 1 | 2011 | 26 | 0.080 |
Why?
|
| Plasmids | 3 | 2002 | 273 | 0.080 |
Why?
|
| Heterografts | 3 | 2016 | 116 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 2015 | 521 | 0.080 |
Why?
|
| Thyroid Hormones | 1 | 2013 | 350 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2011 | 272 | 0.080 |
Why?
|
| Primary Cell Culture | 2 | 2020 | 83 | 0.080 |
Why?
|
| Hedgehog Proteins | 2 | 2013 | 105 | 0.080 |
Why?
|
| STAT Transcription Factors | 1 | 2009 | 18 | 0.080 |
Why?
|
| Doxycycline | 1 | 2010 | 37 | 0.080 |
Why?
|
| Integrases | 1 | 2010 | 66 | 0.080 |
Why?
|
| Homeodomain Proteins | 3 | 2015 | 556 | 0.080 |
Why?
|
| COP9 Signalosome Complex | 1 | 2009 | 2 | 0.080 |
Why?
|
| SKP Cullin F-Box Protein Ligases | 1 | 2009 | 4 | 0.080 |
Why?
|
| Connective Tissue Growth Factor | 1 | 2009 | 16 | 0.070 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 411 | 0.070 |
Why?
|
| Proteins | 2 | 2005 | 803 | 0.070 |
Why?
|
| Peptide Hydrolases | 1 | 2009 | 99 | 0.070 |
Why?
|
| Nuclear Export Signals | 1 | 2008 | 2 | 0.070 |
Why?
|
| Genetic Therapy | 2 | 2003 | 366 | 0.070 |
Why?
|
| Prostatic Neoplasms | 2 | 2011 | 1775 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2010 | 309 | 0.070 |
Why?
|
| Proto-Oncogene Proteins c-myc | 2 | 2020 | 151 | 0.070 |
Why?
|
| Spatio-Temporal Analysis | 2 | 2019 | 26 | 0.070 |
Why?
|
| Fibrosarcoma | 1 | 2009 | 89 | 0.070 |
Why?
|
| T-Lymphocytes | 2 | 2020 | 1275 | 0.070 |
Why?
|
| Microscopy, Electron | 1 | 2009 | 439 | 0.070 |
Why?
|
| Multiprotein Complexes | 1 | 2009 | 106 | 0.070 |
Why?
|
| Kidney Tubules | 1 | 2008 | 91 | 0.070 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2015 | 1077 | 0.070 |
Why?
|
| Amino Acid Sequence | 3 | 2015 | 2012 | 0.070 |
Why?
|
| Forkhead Transcription Factors | 1 | 2009 | 174 | 0.070 |
Why?
|
| Cell Adhesion | 3 | 2016 | 416 | 0.070 |
Why?
|
| Ubiquitin | 1 | 2008 | 95 | 0.070 |
Why?
|
| Head and Neck Neoplasms | 1 | 2015 | 1073 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2017 | 526 | 0.070 |
Why?
|
| beta-Galactosidase | 2 | 2005 | 67 | 0.070 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 2 | 2020 | 31 | 0.070 |
Why?
|
| Kidney | 2 | 2010 | 1111 | 0.070 |
Why?
|
| Rats, Inbred SHR | 2 | 2019 | 33 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2011 | 636 | 0.070 |
Why?
|
| Time Factors | 4 | 2005 | 5410 | 0.070 |
Why?
|
| Protein Inhibitors of Activated STAT | 1 | 2007 | 6 | 0.070 |
Why?
|
| Bone Resorption | 1 | 2007 | 43 | 0.060 |
Why?
|
| Osteoclasts | 1 | 2007 | 35 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 729 | 0.060 |
Why?
|
| Muscle Proteins | 1 | 2007 | 129 | 0.060 |
Why?
|
| Cellular Microenvironment | 2 | 2020 | 31 | 0.060 |
Why?
|
| NIH 3T3 Cells | 3 | 2017 | 111 | 0.060 |
Why?
|
| Pneumonia | 2 | 2020 | 193 | 0.060 |
Why?
|
| Receptors, Virus | 1 | 2006 | 74 | 0.060 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2006 | 60 | 0.060 |
Why?
|
| Luciferases | 3 | 2013 | 129 | 0.060 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 1 | 2005 | 7 | 0.060 |
Why?
|
| Survival Analysis | 3 | 2015 | 1524 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2015 | 476 | 0.060 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2005 | 26 | 0.060 |
Why?
|
| Heart Function Tests | 2 | 2016 | 28 | 0.060 |
Why?
|
| Liver | 1 | 2010 | 1210 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2003 | 274 | 0.060 |
Why?
|
| Tissue Array Analysis | 2 | 2015 | 134 | 0.050 |
Why?
|
| Leupeptins | 1 | 2004 | 21 | 0.050 |
Why?
|
| Polyribosomes | 2 | 2009 | 20 | 0.050 |
Why?
|
| Consensus Sequence | 1 | 2004 | 65 | 0.050 |
Why?
|
| Zinc Fingers | 1 | 2004 | 58 | 0.050 |
Why?
|
| Multienzyme Complexes | 1 | 2004 | 61 | 0.050 |
Why?
|
| Lithium | 1 | 2004 | 61 | 0.050 |
Why?
|
| Transgenes | 1 | 2005 | 171 | 0.050 |
Why?
|
| Cardiac Output, Low | 1 | 2004 | 12 | 0.050 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 49 | 0.050 |
Why?
|
| Amino Acid Motifs | 1 | 2004 | 119 | 0.050 |
Why?
|
| Blotting, Northern | 2 | 2002 | 244 | 0.050 |
Why?
|
| Heparin-binding EGF-like Growth Factor | 2 | 2016 | 6 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2004 | 88 | 0.050 |
Why?
|
| Immunoblotting | 3 | 2015 | 273 | 0.050 |
Why?
|
| HCT116 Cells | 2 | 2017 | 162 | 0.050 |
Why?
|
| Fetal Diseases | 1 | 2004 | 75 | 0.050 |
Why?
|
| Polymerase Chain Reaction | 2 | 2006 | 894 | 0.050 |
Why?
|
| Introns | 1 | 2005 | 300 | 0.050 |
Why?
|
| Lymphocyte Activation | 2 | 2009 | 797 | 0.050 |
Why?
|
| Genes, erbB-2 | 1 | 2003 | 25 | 0.050 |
Why?
|
| Fibrosis | 2 | 2015 | 230 | 0.050 |
Why?
|
| Serine | 2 | 2019 | 105 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2024 | 286 | 0.050 |
Why?
|
| Case-Control Studies | 2 | 2017 | 1931 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-crk | 1 | 2022 | 6 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2017 | 608 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 2001 | 291 | 0.050 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2022 | 58 | 0.040 |
Why?
|
| Histone Deacetylases | 2 | 2014 | 86 | 0.040 |
Why?
|
| Gene Library | 1 | 2002 | 126 | 0.040 |
Why?
|
| Vascular Remodeling | 1 | 2021 | 21 | 0.040 |
Why?
|
| Mutagenesis | 1 | 2002 | 192 | 0.040 |
Why?
|
| Blastocyst | 1 | 2001 | 34 | 0.040 |
Why?
|
| Exons | 2 | 2017 | 450 | 0.040 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 123 | 0.040 |
Why?
|
| Interleukin-4 | 1 | 2001 | 134 | 0.040 |
Why?
|
| DNA Primers | 3 | 2009 | 531 | 0.040 |
Why?
|
| DNA, Complementary | 1 | 2002 | 384 | 0.040 |
Why?
|
| Matrix Metalloproteinase 2 | 2 | 2011 | 48 | 0.040 |
Why?
|
| Antiporters | 1 | 2020 | 18 | 0.040 |
Why?
|
| Bcl-2-Like Protein 11 | 1 | 2020 | 25 | 0.040 |
Why?
|
| Azepines | 1 | 2020 | 28 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2003 | 454 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2016 | 1917 | 0.040 |
Why?
|
| Cell Plasticity | 1 | 2020 | 14 | 0.040 |
Why?
|
| Glutamine | 1 | 2020 | 93 | 0.040 |
Why?
|
| 4-Butyrolactone | 1 | 2020 | 4 | 0.040 |
Why?
|
| Pyrazines | 1 | 2020 | 93 | 0.040 |
Why?
|
| Transcription Factor RelA | 1 | 2020 | 39 | 0.040 |
Why?
|
| Developmental Biology | 1 | 2020 | 29 | 0.040 |
Why?
|
| Endocardial Cushion Defects | 1 | 2019 | 3 | 0.040 |
Why?
|
| Wnt1 Protein | 1 | 2019 | 27 | 0.040 |
Why?
|
| Triazoles | 1 | 2020 | 110 | 0.040 |
Why?
|
| Thiophenes | 1 | 2020 | 44 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2020 | 54 | 0.040 |
Why?
|
| Stroke Volume | 1 | 2022 | 438 | 0.040 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2019 | 64 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2015 | 361 | 0.040 |
Why?
|
| Benzamides | 1 | 2020 | 246 | 0.040 |
Why?
|
| Autonomic Pathways | 1 | 2019 | 4 | 0.040 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2015 | 170 | 0.040 |
Why?
|
| Gene Amplification | 1 | 2020 | 140 | 0.040 |
Why?
|
| Mammary Neoplasms, Animal | 1 | 2019 | 58 | 0.040 |
Why?
|
| Cell Count | 1 | 2019 | 197 | 0.040 |
Why?
|
| Yolk Sac | 1 | 2019 | 5 | 0.040 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 136 | 0.040 |
Why?
|
| Tenascin | 1 | 1999 | 9 | 0.040 |
Why?
|
| DNA | 1 | 2005 | 1265 | 0.040 |
Why?
|
| Tumor Suppressor p53-Binding Protein 1 | 1 | 2019 | 12 | 0.040 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1999 | 18 | 0.040 |
Why?
|
| Tricuspid Valve | 1 | 2019 | 94 | 0.040 |
Why?
|
| Ascorbic Acid | 1 | 2019 | 40 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 85 | 0.040 |
Why?
|
| Endoplasmic Reticulum, Rough | 1 | 1998 | 1 | 0.040 |
Why?
|
| NADPH Oxidases | 1 | 2019 | 85 | 0.040 |
Why?
|
| Lymphatic Metastasis | 2 | 2015 | 504 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2020 | 160 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2021 | 1245 | 0.040 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 1999 | 46 | 0.040 |
Why?
|
| Colchicine | 1 | 1998 | 21 | 0.040 |
Why?
|
| Oxadiazoles | 1 | 2018 | 37 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2020 | 218 | 0.040 |
Why?
|
| Stress, Physiological | 1 | 2020 | 246 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 88 | 0.040 |
Why?
|
| Heterocyclic Compounds, 3-Ring | 1 | 2018 | 42 | 0.040 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2001 | 481 | 0.040 |
Why?
|
| S Phase | 1 | 2018 | 64 | 0.030 |
Why?
|
| G1 Phase | 1 | 2018 | 64 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 156 | 0.030 |
Why?
|
| Cyclosporine | 2 | 2009 | 241 | 0.030 |
Why?
|
| Mice, Mutant Strains | 2 | 2009 | 224 | 0.030 |
Why?
|
| Gene Knock-In Techniques | 1 | 2018 | 28 | 0.030 |
Why?
|
| DNA Replication | 1 | 2019 | 168 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1997 | 26 | 0.030 |
Why?
|
| Protein Domains | 1 | 2018 | 161 | 0.030 |
Why?
|
| Consensus | 1 | 2020 | 368 | 0.030 |
Why?
|
| Madin Darby Canine Kidney Cells | 1 | 2017 | 23 | 0.030 |
Why?
|
| Hematopoiesis | 1 | 2019 | 183 | 0.030 |
Why?
|
| A549 Cells | 1 | 2017 | 52 | 0.030 |
Why?
|
| Cell Size | 1 | 1997 | 71 | 0.030 |
Why?
|
| Pyrroles | 1 | 2018 | 165 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2020 | 467 | 0.030 |
Why?
|
| Transformation, Genetic | 1 | 2017 | 38 | 0.030 |
Why?
|
| Sirtuins | 1 | 2018 | 79 | 0.030 |
Why?
|
| Netrin Receptors | 1 | 2017 | 7 | 0.030 |
Why?
|
| CD24 Antigen | 1 | 2017 | 6 | 0.030 |
Why?
|
| Taxoids | 1 | 2017 | 126 | 0.030 |
Why?
|
| Aged | 2 | 2012 | 20434 | 0.030 |
Why?
|
| Proteoglycans | 1 | 2017 | 122 | 0.030 |
Why?
|
| Adult | 3 | 2012 | 27918 | 0.030 |
Why?
|
| Dogs | 1 | 2017 | 634 | 0.030 |
Why?
|
| Heterozygote | 1 | 2017 | 382 | 0.030 |
Why?
|
| Cell Adhesion Molecules | 1 | 2017 | 174 | 0.030 |
Why?
|
| Versicans | 1 | 2016 | 7 | 0.030 |
Why?
|
| SOX9 Transcription Factor | 1 | 2016 | 28 | 0.030 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2016 | 12 | 0.030 |
Why?
|
| Stress Fibers | 1 | 2016 | 23 | 0.030 |
Why?
|
| Embryonic Development | 2 | 2011 | 83 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2016 | 57 | 0.030 |
Why?
|
| Pancreatic Stellate Cells | 1 | 2016 | 2 | 0.030 |
Why?
|
| Pyrimidines | 1 | 2018 | 384 | 0.030 |
Why?
|
| Regenerative Medicine | 1 | 2016 | 28 | 0.030 |
Why?
|
| Pancreatic Ducts | 1 | 2016 | 29 | 0.030 |
Why?
|
| Homeobox Protein Nkx-2.5 | 1 | 2015 | 13 | 0.030 |
Why?
|
| Sulfones | 1 | 2016 | 47 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2018 | 257 | 0.030 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2016 | 87 | 0.030 |
Why?
|
| Mice, 129 Strain | 1 | 2015 | 56 | 0.030 |
Why?
|
| Secondary Metabolism | 1 | 2015 | 2 | 0.030 |
Why?
|
| ATPases Associated with Diverse Cellular Activities | 1 | 2015 | 4 | 0.030 |
Why?
|
| Pericytes | 1 | 2015 | 14 | 0.030 |
Why?
|
| Focal Adhesion Kinase 1 | 1 | 2015 | 30 | 0.030 |
Why?
|
| Cantharidin | 1 | 2015 | 2 | 0.030 |
Why?
|
| Okadaic Acid | 1 | 2015 | 10 | 0.030 |
Why?
|
| Mast Cells | 1 | 2016 | 96 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2019 | 660 | 0.030 |
Why?
|
| Genome, Human | 1 | 2020 | 823 | 0.030 |
Why?
|
| Pulmonary Edema | 1 | 2015 | 53 | 0.030 |
Why?
|
| Bronchioles | 1 | 2015 | 2 | 0.030 |
Why?
|
| Nitriles | 1 | 2016 | 154 | 0.030 |
Why?
|
| Prolyl Hydroxylases | 1 | 2015 | 4 | 0.030 |
Why?
|
| Activin Receptors, Type I | 1 | 2015 | 13 | 0.030 |
Why?
|
| Ketoglutaric Acids | 1 | 2015 | 15 | 0.030 |
Why?
|
| GTPase-Activating Proteins | 1 | 2015 | 68 | 0.030 |
Why?
|
| Animals, Genetically Modified | 1 | 2015 | 186 | 0.030 |
Why?
|
| Neuropilin-1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Mortality | 1 | 2016 | 156 | 0.030 |
Why?
|
| rho-Associated Kinases | 1 | 2016 | 161 | 0.030 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2015 | 66 | 0.030 |
Why?
|
| Acute Lung Injury | 1 | 2015 | 68 | 0.030 |
Why?
|
| Zebrafish | 1 | 2017 | 339 | 0.030 |
Why?
|
| Rats, Wistar | 1 | 2015 | 300 | 0.030 |
Why?
|
| Blood Vessels | 1 | 2015 | 91 | 0.030 |
Why?
|
| Phosphotyrosine | 1 | 2014 | 31 | 0.030 |
Why?
|
| Length of Stay | 1 | 2018 | 828 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2015 | 41 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 85 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2015 | 96 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2015 | 86 | 0.030 |
Why?
|
| Cardiac Myosins | 1 | 2014 | 19 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2015 | 155 | 0.030 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2016 | 131 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2015 | 436 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 66 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2014 | 79 | 0.030 |
Why?
|
| Protein Isoforms | 2 | 2008 | 295 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2018 | 9099 | 0.030 |
Why?
|
| Elastin | 1 | 2013 | 8 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2013 | 13 | 0.020 |
Why?
|
| Smad2 Protein | 1 | 2013 | 24 | 0.020 |
Why?
|
| Quality of Life | 1 | 2022 | 1780 | 0.020 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 51 | 0.020 |
Why?
|
| Zinc Finger Protein GLI1 | 1 | 2013 | 21 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2015 | 299 | 0.020 |
Why?
|
| Skull | 1 | 2015 | 270 | 0.020 |
Why?
|
| Immune Tolerance | 1 | 2016 | 375 | 0.020 |
Why?
|
| Heart Rate | 1 | 2015 | 505 | 0.020 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2014 | 156 | 0.020 |
Why?
|
| Epidermis | 1 | 2013 | 103 | 0.020 |
Why?
|
| Creatine Kinase, MB Form | 1 | 2012 | 6 | 0.020 |
Why?
|
| Tryptophan Hydroxylase | 1 | 2012 | 11 | 0.020 |
Why?
|
| Filamins | 1 | 2012 | 19 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2018 | 2479 | 0.020 |
Why?
|
| Sarcoplasmic Reticulum Calcium-Transporting ATPases | 1 | 2012 | 29 | 0.020 |
Why?
|
| Transglutaminases | 1 | 2012 | 41 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2012 | 41 | 0.020 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2012 | 49 | 0.020 |
Why?
|
| Protein Subunits | 1 | 2012 | 120 | 0.020 |
Why?
|
| Animals, Outbred Strains | 1 | 2012 | 16 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2012 | 111 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2012 | 147 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2012 | 162 | 0.020 |
Why?
|
| Gels | 1 | 2012 | 51 | 0.020 |
Why?
|
| Oncogenes | 1 | 2012 | 100 | 0.020 |
Why?
|
| Infant | 1 | 2018 | 3220 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2012 | 87 | 0.020 |
Why?
|
| Dendritic Cells | 1 | 2016 | 536 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3829 | 0.020 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2012 | 80 | 0.020 |
Why?
|
| Cell Polarity | 1 | 2012 | 118 | 0.020 |
Why?
|
| Serotonin | 1 | 2012 | 209 | 0.020 |
Why?
|
| Drosophila | 1 | 2015 | 539 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 124 | 0.020 |
Why?
|
| Embryo Loss | 1 | 2010 | 5 | 0.020 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-3 | 1 | 2010 | 4 | 0.020 |
Why?
|
| Antibodies | 1 | 2011 | 348 | 0.020 |
Why?
|
| Cell Communication | 1 | 2011 | 216 | 0.020 |
Why?
|
| Gestational Age | 1 | 2011 | 333 | 0.020 |
Why?
|
| Gene Knockout Techniques | 1 | 2009 | 84 | 0.020 |
Why?
|
| Binding, Competitive | 1 | 2009 | 141 | 0.020 |
Why?
|
| Clonal Anergy | 1 | 2009 | 32 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2012 | 702 | 0.020 |
Why?
|
| Calcineurin Inhibitors | 1 | 2009 | 53 | 0.020 |
Why?
|
| Mercuric Chloride | 1 | 2008 | 11 | 0.020 |
Why?
|
| Models, Cardiovascular | 1 | 2009 | 92 | 0.020 |
Why?
|
| Transcriptome | 1 | 2014 | 762 | 0.020 |
Why?
|
| RANK Ligand | 1 | 2008 | 11 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2015 | 1448 | 0.020 |
Why?
|
| Caveolin 1 | 1 | 2008 | 24 | 0.020 |
Why?
|
| Matrix Metalloproteinases | 1 | 2008 | 30 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2009 | 948 | 0.020 |
Why?
|
| Body Patterning | 1 | 2009 | 214 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2008 | 119 | 0.020 |
Why?
|
| Down Syndrome | 1 | 2007 | 51 | 0.020 |
Why?
|
| Nervous System | 1 | 2008 | 92 | 0.020 |
Why?
|
| Child | 1 | 2018 | 7355 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 2465 | 0.020 |
Why?
|
| Coxsackie and Adenovirus Receptor-Like Membrane Protein | 1 | 2006 | 12 | 0.020 |
Why?
|
| Chromones | 1 | 2005 | 31 | 0.010 |
Why?
|
| Protein Methyltransferases | 1 | 2005 | 15 | 0.010 |
Why?
|
| Adolescent | 1 | 2018 | 9606 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2005 | 94 | 0.010 |
Why?
|
| Polycomb Repressive Complex 2 | 1 | 2005 | 32 | 0.010 |
Why?
|
| Morpholines | 1 | 2005 | 61 | 0.010 |
Why?
|
| COS Cells | 1 | 2005 | 164 | 0.010 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 1 | 2005 | 41 | 0.010 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2005 | 20 | 0.010 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2005 | 14 | 0.010 |
Why?
|
| Microscopy, Acoustic | 1 | 2004 | 8 | 0.010 |
Why?
|
| Placental Circulation | 1 | 2004 | 11 | 0.010 |
Why?
|
| Blood Circulation | 1 | 2004 | 29 | 0.010 |
Why?
|
| Threonine | 1 | 2004 | 33 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2003 | 54 | 0.010 |
Why?
|
| Myocardial Contraction | 1 | 2004 | 188 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 476 | 0.010 |
Why?
|
| Germ-Line Mutation | 1 | 2006 | 381 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2003 | 128 | 0.010 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2003 | 201 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2002 | 108 | 0.010 |
Why?
|
| I-kappa B Proteins | 1 | 2002 | 47 | 0.010 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2002 | 74 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2003 | 203 | 0.010 |
Why?
|
| fas Receptor | 1 | 2002 | 73 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2002 | 115 | 0.010 |
Why?
|
| Host Cell Factor C1 | 1 | 2001 | 6 | 0.010 |
Why?
|
| Octamer Transcription Factor-2 | 1 | 2001 | 3 | 0.010 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2001 | 20 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2004 | 889 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 985 | 0.010 |
Why?
|
| Embryo Implantation | 1 | 2001 | 24 | 0.010 |
Why?
|
| Interleukin-2 | 1 | 2001 | 244 | 0.010 |
Why?
|
| Alternative Splicing | 1 | 2001 | 219 | 0.010 |
Why?
|
| Respirovirus | 1 | 1999 | 4 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1999 | 68 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 1999 | 66 | 0.010 |
Why?
|
| Integrin beta3 | 1 | 1999 | 31 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 1999 | 75 | 0.010 |
Why?
|
| Liposomes | 1 | 1999 | 98 | 0.010 |
Why?
|
| Genetic Vectors | 1 | 1999 | 422 | 0.010 |
Why?
|